Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida

被引:22
|
作者
Light, Michael [2 ]
Bauman, Jay [1 ]
Mavunda, Kunjana [3 ]
Malinoski, Frank [4 ]
Eggleston, Mark [4 ]
机构
[1] Sci & Tech Evalut Pharmaceut Inc, Raleigh, NC USA
[2] Univ Miami, Dept Pediat, Batchelor Childrens Res Inst, Miami, FL 33152 USA
[3] Int Travel Clin, Pediat Pulm Ctr, Miami, FL USA
[4] Medimmune Inc, Dept Med Affairs, Gaithersburg, MD 20878 USA
关键词
respiratory syncytial virus; seasonality; prophylaxis; Florida; hospitalizations;
D O I
10.1097/INF.0b013e318168daf1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Florida experiences year-round outbreaks of respiratory syncytial virus (RSV), but it is unknown if there is a correlation between RSV virology data and disease-related hospitalizations. We analyzed RSV surveillance and hospitalization data for the state of Florida to determine if there is an association between seasonal virology data and the incidence of International Classification of Diseases, 9th revision, clinical modification (ICD-9-CM) coded hospitalizations for RSV lower respiratory tract illness. Methods: We conducted a retrospective analysis for each of 5 regions of Florida for 4 years (2001-2004) of monthly RSV surveillance data presented on the Florida Department of Health web-site and hospitalization data provided by the Agency for Health Care Administration. RSV was considered present when >= 10% of laboratory tests were positive in a given month and the duration of seasons was determined by the number of consecutive months threshold values were exceeded. Hospitalizations in children 24 months of age and younger were defined as RSV related if any of the following RSV-specific ICD-9-CM codes appeared on the discharge summary: 079.6 RSV; 466.11 acute bronchiolitis caused by RSV; and 480.1 pneumonia caused by RSV. Results: RSV circulated year-round statewide and seasons ranged from 7-8 months in the southwest, northwest, and north regions of Florida to 11-12 months in the central and southeast regions, respectively. More than 23,000 children younger than 24 months of age were hospitalized throughout the state for an RSV-related illness during the 4-year period, with almost 20,000 (86%) of the admissions in infants less than 12 months of age. There were 23 hospitalizations yearly per 1000 births and more than 90% of discharges occurred during the defined RSV seasons. Conclusions: To our knowledge, this is the first study to demonstrate a positive correlation between RSV test data and hospitalizations both statewide and for individual regions within Florida. It would be prudent for clinicians to obtain results of local RSV virology data to guide decisions on timing of prophylaxis to prevent RSV hospitalizations.
引用
收藏
页码:512 / 518
页数:7
相关论文
共 50 条
  • [1] Detection and molecular characterization of respiratory syncytial virus (RSV) in children with lower respiratory tract infections
    Colak, Dilek
    Saglik, Imran
    Mutlu, Derya
    Sarinoglu, Rabia Can
    Inan, Dilara
    Gunay, Nurgul
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S72 - S72
  • [2] Risk factors for lower respiratory tract illness during the first two respiratory syncytial virus (RSV) seasons
    Cron, S
    Wells, J
    Jewell, A
    Boland, J
    Byrd, R
    Fan, L
    Piedra, PA
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 313 - 313
  • [3] Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections
    Rodriguez, WJ
    Gruber, WC
    Welliver, RC
    Groothuis, JR
    Simoes, EAF
    Meissner, HC
    Hemming, VG
    Hall, CB
    Lepow, ML
    Rosas, AJ
    Robertsen, C
    Kramer, AA
    Kim, HW
    Arrobio, J
    Milburn, C
    Baker, J
    Satterwhite, P
    Steel, L
    Bender, P
    King, S
    Levin, M
    Aronoff, S
    Baer, L
    Sanchez, J
    Top, FH
    Hensen, SA
    Peterson, MB
    [J]. PEDIATRICS, 1997, 99 (03) : 454 - 461
  • [4] Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)
    Bergeron, Harrison C.
    Tripp, Ralph A.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (01) : 23 - 29
  • [5] Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children
    Rodriguez, WJ
    Gruber, WC
    Groothuis, JR
    Simoes, EAF
    Rosas, AJ
    Lepow, M
    Kramer, A
    Hemming, V
    Kim, HW
    Arrobio, J
    Milburn, C
    Baker, J
    Bender, P
    Satterwhite, P
    Steele, L
    King, S
    Levin, M
    Hensen, S
    Aronoff, S
    Baer, L
    Sanchez, J
    Top, FH
    [J]. PEDIATRICS, 1997, 100 (06) : 937 - 942
  • [7] RESPIRATORY SYNCYTIAL VIRUS (RSV) IN IMMUNOCOMPROMISED CHILDREN (IC)
    HALL, CB
    MACDONALD, NE
    KLEMPERER, MR
    ETTINGER, LJ
    [J]. PEDIATRIC RESEARCH, 1981, 15 (04) : 613 - 613
  • [8] CORRELATION BETWEEN RESPIRATORY SYNCYTIAL VIRUS (RSV) GLYCOPROTEIN SPECIFIC MATERNAL ANTIBODIES AND RSV DISEASE OF INFANTS
    HILDRETH, SW
    BELSHE, RB
    PARADISO, PR
    SMITH, DH
    [J]. PEDIATRIC RESEARCH, 1987, 21 (04) : A326 - A326
  • [9] The adult respiratory syncytial virus The Respiratory Syncytial Virus (RSV) in Adults
    Frenzen, F.
    Mueller, G.
    Frenzen, K.
    [J]. PNEUMOLOGIE, 2020, 74 (06): : 374 - 386
  • [10] Respiratory Syncytial Virus (RSV) Update
    Krilov, Leonard R.
    Roberts Jr, Norbert
    [J]. VIRUSES-BASEL, 2022, 14 (10):